Latest filing published 31 Jan 2018 for Acadia Pharmaceuticals INC, €953k.
Filing timeline
BuySaleInsider track record
Glenn Baity: trading record in brief
All filings by Glenn Baity on record concern Acadia Pharmaceuticals Inc. The record holds 70 filings, for trades running from 27 November 2012 to 29 January 2018.
The open-market record consists of 28 sales worth €12.1M, with no purchase. Besides market trades, the filings include 42 option exercises. So far in 2018, the count stands at no purchases and 2 sales.
Most recently, on 31 January 2018, the filings show an open-market sale worth €953k in Acadia Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Glenn Baity
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 36,558 shares@ US$32.398.9% of flowCommon StockSEC:0001415889-18-000158:0
- 50,179 shares@ US$2.180.9% of flowCommon StockSEC:0001415889-18-000043:0
- 74,321 shares@ US$2.181.3% of flowCommon StockSEC:0001415889-18-000014:0
- 74,321 shares@ US$30.1417.4% of flowCommon StockSEC:0001415889-18-000014:1
- 6,500 shares@ US$1.620.1% of flowCommon StockSEC:0001415889-17-001636:0
- 4,500 shares@ US$2.180.1% of flowCommon StockSEC:0001415889-17-001636:1
- 1,000 shares@ US$2.180.0% of flowCommon StockSEC:0001415889-17-001636:2
- 7,500 shares@ US$1.620.1% of flowCommon StockSEC:0001415889-17-001636:3
- 20,000 shares@ US$2.000.3% of flowCommon StockSEC:0001415889-17-001636:4
- 37,500 shares@ US$40.9112.2% of flowCommon StockSEC:0001415889-17-001636:5
- 16,507 shares@ US$1.620.2% of flowCommon StockSEC:0001415889-17-001447:0
- 26,507 shares@ US$34.877.2% of flowCommon StockSEC:0001415889-17-001447:1
- 922 shares@ US$1.550.0% of flowCommon StockSEC:0001415889-17-001378:0
- 13,400 shares@ US$1.620.2% of flowCommon StockSEC:0001415889-17-001378:1
- 14,322 shares@ US$34.884.0% of flowCommon StockSEC:0001415889-17-001378:2
- 6,500 shares@ US$1.620.1% of flowCommon StockSEC:0001415889-17-001348:0
- 28,097 shares@ US$1.620.4% of flowCommon StockSEC:0001415889-17-001265:0
- 38,097 shares@ US$30.009.2% of flowCommon StockSEC:0001415889-17-001265:1
- 1,903 shares@ US$1.620.0% of flowCommon StockSEC:0001415889-17-001046:0
- 1,903 shares@ US$30.000.5% of flowCommon StockSEC:0001415889-17-001046:1
- 14,093 shares@ US$1.620.2% of flowCommon StockSEC:0001415889-17-000785:0
- 20,000 shares@ US$8.321.5% of flowCommon StockSEC:0001415889-17-000281:0
- 6,365 shares@ US$1.640.1% of flowCommon StockSEC:0001415889-17-000281:1
- 26,365 shares@ US$39.669.2% of flowCommon StockSEC:0001415889-17-000281:2
- 21,078 shares@ US$1.550.3% of flowCommon StockSEC:0001415889-17-000182:0
25 of 66 declarations
